Adjukines is mandated to create a commercialization arm of the hospital to offer ~25 new technical services for broader and better patient care;
Adjukines unearthed two hidden IP assets developed by the hospital. Adjukines helped the hospital patent and licensed them to industry;
Additional mandate to unearth, support, and nurture entrepreneurs among the medical fraternity ;
Adjukines has a >3 years long association with the hospital for IP, tech commercialization, creation of a separate commercialization arm, and spin-off support.
A leading stem cell organization – A retainer model
Adjukines works as team member of the organization for
End-to-end IP management services;
Out-license / Commercialization of IP/know-how assets;
Management of all external affairs, especially with the industrial circles (example, industry-sponsored R&D projects).
Scientific Capability Sourcing - A Boston based biotech start-up
The Start-up was looking for a hospital in India to validate its novel antibody;
Adjukines structured the validation requirements and prepared a techno-commercial pitch;
Identified hospitals that have required infrastructure and scientific resources, opened dialogues, negotiated the arrangement;
Closed the deal in ~2 month time with mutually agreed legal agreements in place.
R&D collaboration & commercialization deal – A case
Adjukines successfully championed a deal between a US-based company and an Indian organization;
The US-based company developed a lentiviral vector-based strategy to treat hemophilia A;
A collaboration arrangement was structured between the parties to jointly conduct trials of the Vector, and commercialize the same in the specified territories of the world;
Adjukines played role in the development of pitch, lead generation, techno-legal-commercial negotiation, pricing, term sheet, and closure of the transaction through execution of legal instruments.
IP out-licensing deal – A case
An institutional client of Adjukines developed a novel external ventricular drainage monitoring device;
Adjukines reviewed the USPs of the technology, and marketed it among different commercial players;
Persuaded the potential licensees, negotiated techno-legal-commercial terms, and helped the institute structure the entire licensing deal;
The technology transferred to the licensee, who in turn launched the product in the market.
R&D collaboration & commercialization deal – A case
A French company developed an advanced automated solution for high-speed biomedical analysis of various pathogens;
Adjukines championed the transaction between the company and an Indian organization to co-validate and co-commercialize the solution;
Adjukines facilitated the transaction between the two parties on mutually agreed terms with suitable legal instruments in place.
IP co-development & in-licensing deal – A case
Adjukines was commissioned by a Bangalore based company to initiate and close a tech in-licensing deal for a novel thrombin inhibitor - an IP asset developed by a foreign group with patents under prosecution in ~26 countries worldwide;
Team Adjukines represented the client and performed
techno-legal-commercial due diligence of the asset;
techno-legal-commercial negotiations;
IP and prosecution strategy pursuant to deal;
NDA, MTA, term sheet, and licensing agreement;
transfer of data/know-how/IP prosecution rights, enforcement of the agreement from different perspectives.
IP intelligence and analytics – A few cases
Adjukines delivered an analytical report to a leading pharma manufacturer related to off-patented Biologics and small molecules for a set of defined therapeutic areas, which have been approved by USFDA, DCGI / CDSCO and EMA. This helped client orient its new product development, manufacturing and marketing operations.
A venture-invested company commissioned Adjukines to perform landscape and freedom-to-operate analysis for its simulation-driven diagnostic product. The client leveraged the analysis to (a) make/refine territory-wise commercialization plans (b) protect its own tech/product through copyrights and patents – an IP strategy recommended by Adjukines.
A series-A funded start-up, while exploring the next round of investments, engaged Adjukines to develop the IP pitch, and take it through investors’ IP due diligence processes. Adjukines provided IP intelligence support and helped the start-up respond to investors’ IP and related queries, thereby contributed in the execution of investment agreement.
Adjukines conducted a comprehensive IP audit for an institute having a large IP portfolio (~200 patents). In a nut shell, Adjukines’s job was to categorize them into ‘to be pursued’ and ‘not to be pursued’ with defendable justifications thereof from enforceability, commercializability and budget point of views. This helped the institute align its financial resources with IP assets.
